1.
HIV Treatment Bulletin
; 23:16-16, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2091823
2.
HIV Treatment Bulletin
; 23:17-17, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2093077
3.
HIV Treatment Bulletin
; 23:28-28, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2092334
ABSTRACT
WATERLIT : Results from a randomised study reported no benefit of daily oral melatonin (2 mg QD) for 12 weeks compared to placebo as prophylaxis against SARS-CoV-2 in 314 Spanish health workers
4.
HIV Treatment Bulletin
; 23:18-18, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2092333
ABSTRACT
WATERLIT : The rapid development of vaccines against COVID-19 led many people to question whether similar investment could have achieved an effective HIV vaccine
5.
HIV Treatment Bulletin
; 23:17-17, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2091860
6.
Engineering News
; 42(16), 2022.
Article
in English
| Africa Wide Information | ID: covidwho-1970549
7.
HIV Treatment Bulletin
; 23:8-8, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-1970361
8.
HIV Treatment Bulletin
; 22:9-10, 2021.
Article
in English
| Africa Wide Information | ID: covidwho-1661023
ABSTRACT
WATERLIT : Results from a double-blind, randomised, placebo-controlled, phase 2 dose-range finding study reported faster viral load clearance after five days using oral molnupiravir at the highest dose